Infant Colonization With Methicillin-Resistant Staphylococcus aureus or Vancomycin-Resistant Enterococci Preceding Neonatal Intensive Care Unit Discharge.
Rates of colonization with methicillin-resistant Staphylococcus aureus (MRSA) and/or vancomycin-resistant enterococci (VRE) were determined for 1320 infants within 7 days of neonatal intensive care unit discharge. Overall, 4% and 1% of the infants were colonized with MRSA or VRE, respectively. Predictors identified in fixed-effects models were surgery during hospitalization (for MRSA colonization) and prolonged antimicrobial treatment (for VRE colonization).
Departments of Pediatrics.
Sarah A
SA
Clock
Columbia University School of Nursing, New York.|Department of Biostatistics, Columbia University Mailman School of Public Health, New York.
Haomiao
H
Jia
Departments of Pediatrics.
Sameer
S
Patel
Columbia University School of Nursing, New York.
Yu-Hui
YH
Ferng
Departments of Pediatrics.
Luis
L
Alba
Pathology, Columbia University Medical Center, New York.
Susan
S
Whittier
Department of Pediatrics, Weill Cornell Medical College, New York.
Patricia
P
DeLaMora
Departments of Pediatrics.
Setareh
S
Tabibi
Department of Pediatrics, Weill Cornell Medical College, New York.
Jeffrey
J
Perlman
Christiana Neonatal Associates, Christiana Care Health System, Newark, Delaware.
David
D
Paul
Children's Hospital of Philadelphia, Philadelphia, Pennsylvania.
Theoklis
T
Zaoutis
Columbia University School of Nursing, New York.
Elaine
E
Larson
Departments of Pediatrics.|Department of Infection Prevention and Control, NewYork-Presbyterian Hospital, New York.
Lisa
L
Saiman
D000900:Anti-Bacterial Agents / Q000494:pharmacology; D016983:Enterococcus / Q000187:drug effects; D005260:Female; D006760:Hospitalization; D006801:Humans; D007231:Infant, Newborn; D007363:Intensive Care Units, Neonatal; D008297:Male; D055624:Methicillin-Resistant Staphylococcus aureus / Q000187:drug effects / Q000302:isolation & purification*; D008826:Microbial Sensitivity Tests; D011446:Prospective Studies; D012307:Risk Factors; D013203:Staphylococcal Infections / Q000453:epidemiology* / Q000382:microbiology; D013211:Staphylococcus aureus / Q000187:drug effects / Q000472:pathogenicity; D014481:United States; D020713:Vancomycin Resistance; D065507:Vancomycin-Resistant Enterococci / Q000187:drug effects / Q000302:isolation & purification*
D000900:Anti-Bacterial Agents
MRSA; VRE; antimicrobial resistance; colonization; risk factors